NORTH GLASGOW DIVISION LIBRARY & E-LEARNING SERVICE



[pic]

This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgement should be exercised when appraising the material. NHS Greater Glasgow and Clyde libraries take no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites.

The library network prefers to send information by email. Please only provide your address details if you wish to receive the articles (and future bulletins) by post. Please contact your library if you wish assistance in setting up an email account.

Please indicate below the number of any item you wish to order from this bulletin, and return this form to your local library. Or contact your local library directly. For library contact details please visit our website at . It is preferred that articles are sent to you by email; please only complete your address details if you do not wish to receive articles/bulletins by email.

Identifying numbers of items requested [pic]I agree for my details to be held and processed in compliance with the Data Protection Act □

If you would like to receive additional bulletins, please tick the bulletins you would like to receive (there is no limit), ensure your name and email details (or address details) are on the front cover, and return to the library address given above.

| A&E | Healthy Heart |

|Allied Health Professionals |IT |

|Alzheimer’s disease |Lung Cancer |

|Ambulatory care |Medicine for the Elderly |

|Anaesthesia |Mental Health in the community |

|Asthma |Multiple Sclerosis |

|Breast Cancer |Neonatal Nursing and Midwifery |

|Burns/Dermatology/Plastic Surgery |New Books (all sites & Nursing/Midwifery) |

|Cancer: Pain |New Nurse |

|Cancer Supportive Care |Nursing in the community |

|Cancer & the Young Adult |Nutrition |

|Chaplain |Orthopaedics |

|Child Protection |Paediatric Anaesthesia & Pain |

|Clinical Governance |Paediatric Oncology Nursing |

|Community Child Health |Paediatric Physiotherapy |

|Complaints |Paediatric Respiratory Medicine |

|Coronary Intensive and High |Parkinson’s disease |

|Dependency Care (Nursing) |Pharmacy |

|Corporate Services |Prevention & Treatment of Alcohol & |

|Day surgery |Drug Abuse (Nursing) |

|A&E |Rheumatology |

|Dental Care Professionals |Sarcoma |

|Dentistry |School Nurses |

|Digestive Diseases |Speech and Language Therapy |

|Elderly Care Bulletin (Nursing) |Spinal Injuries |

|Epilepsy |Stroke (North Glasgow) |

|Guidelines |Stroke (South Glasgow) |

|Gynaecologic Oncology |Training, Education and Management |

|Head Injury |(Nursing) |

|Head & Neck Cancer | |

|Health Promotion | |

|Healthcare Associated Infection | |

How to Access Electronic Articles

Many of the articles in this bulletin will be available online at the NHS Scotland eLibrary

1. Go to the NHS Scotland eLibrary

2. Click on Journals

3. Type in the journal title and click search.

4. Click on the appropriate title, and then select the supplier you wish to use.

5. Put in your Athens password at the “Athens login” link.

6. Select the correct year, volume, issue and page number for the article you want.

Please note that the journal articles you are accessing may be protected by copyright legislation and there may be a limit on the number of articles you can download or print from any single issue of a journal.  If you obtain a copy via your local library's document request service, you may be required to complete a copyright declaration form.  Consult your local library with any queries, or for further information see the website of the Copyright Licensing Agency at cla.co.uk."

Compiled by KIrsty Coltart

Library Manager

NHS Greater Glasgow & Clyde Library Network

Beatson West of Scotland Cancer Centre

Education Suite

1053 Great Western Road

G12 0YN

0141 301 7285 kirsty.coltart@ggc.scot.nhs.uk

Journals received in the Beatson WoS Cancer Centre Library have been scanned for articles under the topics listed below. I have also included some titles held in other libraries in the Network and a few from OVID databases. Please use links where provided.

General

1.Amar, S. Treatment of metastatic breast cancer: Looking towards the future. Breast Cancer Research and Treatment 2009 114(3): 413-22

2.Balducci, L. Elderly patients with hormone sensitive breast cancer: What do the data show? Cancer Treatment Reviews 2009 35(1): 47-56

3.Frye DK. New options for metastatic breast cancer. Clinical Journal of Oncology Nursing. 13(1):11-8, 2009 Jan.

4.Kuerer HM. Ductal carcinoma in situ: state of the science and roadmap to advance the field. Journal of Clinical Oncology. 27(2):279-88, 2009 Jan 10.

5.Laird, B. Palliative Care in the Elderly Breast Cancer Patient. Clinical Oncology 2009 21(2): 131-139

6.Mackey J. Adjuvant targeted therapy in early breast cancer. Cancer. 115(6):1154-68, 2009 Mar 15.

7.Mahon SM. Metastatic breast cancer: the individualization of therapy. Clinical Journal of Oncology Nursing. 13(1):19-28, 2009 Jan.

8.NICE Guidelines. Advanced breast cancer: diagnosis and treatment 2009 CG81

9.NICE Guidelines. Early and locally advanced breast cancer: diagnosis and treatment 2009. CG80

10.Palmieri FM. Current clinical issues in systemic therapy for metastatic breast cancer. Clinical Journal of Oncology Nursing. 13(1):4-10, 2009 Jan.

11.Sheppard, C. Breast cancer follow up: A randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. European Journal of Oncology Nursing 2009 13(1): 2-8

12.Tipples, K. Optimising Care of Elderly Breast Cancer Patients: a Challenging Priority. Clinical Oncology 2009 21(2): 118-130

Combined Modality Therapies

13.Cancer and Leukemia Group B .Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: A phase II trial (CALGB 8944). Breast Cancer Research and Treatment 2009 113(3): 479-90

14.Chen, J. Impact of MRI-Evaluated Neoadjuvant Chemotherapy Response on Change of Surgical Recommendation in Breast Cancer. Annals of Surgery. 249(3):448-454, March 2009.

15.Diepenmaat, L. The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancer. Radiotherapy and Oncology 2009 91(1): 49-53

16.Floyd, S. Post-mastectomy radiation in large node-negative breast tumors: Does size really matter? Radiotherapy and Oncology 2009 91(1): 33-37

17.Holli K. Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. Journal of Clinical Oncology. 27(6):927-32, 2009 Feb 20.

18.Magne, N. Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patients. Radiotherapy and Oncology 2009 90(1): 116-121

19.Mannino, M. Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: Can radiotherapy ever be safely withheld? Radiotherapy and Oncology 2009 90(1): 14-22

21.Poortmans, P. Impact of the boost dose of 10Gy versus 26Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiotherapy and Oncology 2009 90(1): 80-85

20.Rowell, N. Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: A systematic review. Radiotherapy and Oncology 2009 91(1): 23-32

21.Truong, P. Patients With T1 to T2 Breast Cancer With One to Three Positive Nodes Have Higher Local and Regional Recurrence Risks Compared With Node-Negative Patients After Breast-Conserving Surgery and Whole-Breast Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2009 73(2): 357-364

Drug Therapy

22.Andreetta, C. Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Annals of Oncology 2009 20(2): 265-71

23.de Azambuja E. Long-term benefit of high-dose epirubicin in adjuvant chemotherapy for node-positive breast cancer: 15-year efficacy results of the belgian multicentre study. Journal of Clinical Oncology. 27(5):720-5, 2009 Feb 10.

24.Barnadas A. Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial. British Journal of Cancer. 100(3):442-9, 2009 Feb 10.

25.Baselga J. Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer. Journal of Clinical Oncology. 27(4):526-34, 2009 Feb 1.

26.Chirivella, I. Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients. Breast Cancer Research and Treatment 2009 114(3): 479-84

27.Frye DK. Capecitabine-based combination therapy for breast cancer: implications for nurses. Oncology Nursing Forum. Online. 36(1):105-13, 2009 Jan.

28.Gnant, M. Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer. New England Journal of Medicine. 360(7):679-691, February 12, 2009.

29.Hackshaw A. Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer. Journal of the National Cancer Institute. 101(5):341-9, 2009 Mar 4.

30.Hugh J. Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial. Journal of Clinical Oncology. 27(8):1168-76, 2009 Mar 10.

31.Jones RL. A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer. British Journal of Cancer. 100(2):305-10, 2009 Jan 27.

32.Mariani G. Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer. Nature Clinical Practice Oncology. 6(2):93-104, 2009 Feb.

33.Mathew, J. Neoadjuvant chemotherapy for locally advanced breast cancer: A review of the literature and future directions. European Journal of Surgical Oncology (EJSO) 2009 35(2): 113-122

34.Nielsen, D. HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors. Cancer Treatment Reviews 2009 35(2): 121-136

35.Nieto, Y. High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?. Current Opinion in Oncology. 21(2):150-157, March 2009.

36.Ortmann, O. Adjuvant endocrine therapy for perimenopausal women with early breast cancer. The Breast 2009 18(1): 2-7

37.Prati R. Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy. Cancer. 115(6):1194-202, 2009 Mar 15.

38.Sullivan, P. Should Histologic Type be Taken into Account when Considering Neoadjuvant Chemotherapy in Breast Carcinoma?. Breast Journal. 15(2):146-154, March/April 2009.

Pathology, Staging, Polymorphisms & Biomarkers

39.Brown SB. Is the biology of breast cancer changing? A study of hormone receptor status 1984-1986 and 1996-1997. British Journal of Cancer. 100(5):807-10, 2009 Mar 10.

40.Chang, H. Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. Annals of Oncology 2009 20(2): 272-77

41.Farmer P. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nature Medicine. 15(1):68-74, 2009 Jan.

42.Generali D. Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer. Journal of Clinical Oncology. 27(2):227-34, 2009 Jan 10.

43.Gur-Dedeoglu B. A resampling-based meta-analysis for detection of differential gene expression in breast cancer. BMC Cancer. 8:396, 2008.

44.Markopoulos, C. Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM Greek substudy. Annals of Oncology 2009 20(1): 49-55

45.Patani, N. The clinical significance of sentinel lymph node micrometastasis in breast cancer. Breast Cancer Research and Treatment 2009 114(3): 393-402

46.Rahka, E. Patho-biological aspects of basal-like breast cancer. Breast Cancer Research and Treatment 2009 113(3): 411-22

47.Reinholz, M. Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response. The Lancet Oncology 2009 10(3): 267-277

48.Sotiriou, C. Gene-Expression Signatures in Breast Cancer. New England Journal of Medicine. 360(8):790-800, February 19, 2009.

49.Sullivan, C. Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer. Human Pathology 2009 40(2):156-165

50.Thomas, G. How Age Affects the Biology of Breast Cancer. Clinical Oncology 2009 21(2): 81-85

51.Van der Vegt, B. Microarray methods to identify factors determining breast cancer progression: Potentials, limitations, and challenges. Critical Reviews in Oncology/Hematology 2009 70(1): 1-11

Prognosis, Survival & Risk Factors

52.Beadle, B. Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment Approach. International Journal of Radiation Oncology*Biology*Physics 2009 73(1): 734-744

53.Chlebowski, R. Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women. New England Journal of Medicine. 360(6):573-587, February 5, 2009.

54.Gunter MJ. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute. 101(1):48-60, 2009 Jan 7.

55.Kyndi, M. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c. Radiotherapy and Oncology 2009 90(1): 74-79

56.Lu, W. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: A meta-analysis. Breast Cancer Research and Treatment 2009 114(3): 403-12

57.Rudloff U. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer. 115(6):1203-14, 2009 Mar 15.

58.Schmidt, M. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer_comparison between Adjuvant St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Annals of Oncology 2009 20(2): 258-64

59.Sternfeld B. Physical Activity and Risk of Recurrence and Mortality in Breast Cancer Survivors: Findings from the LACE Study. Cancer Epidemiology, Biomarkers & Prevention. 18(1):87-95, 2009 Jan.

60.van Nes JG. Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients. British Journal of Cancer. 100(3):494-500, 2009 Feb 10.

Radiotherapy & Imaging

61.Alonso-Basanta, M. Coverage of Axillary Lymph Nodes in Supine vs. Prone Breast Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2009 73(1): 745-751

62.Aristei, C. Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy. Radiotherapy and Oncology 2009 90(1): 43-47

63.Berrang, T. 3D Ultrasound Can Contribute to Planning CT to Define the Target for Partial Breast Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2009 73(2): 375-383

64.Caudrelier, JM. Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: Dosimetric evaluation. Radiotherapy and Oncology 2009 90(1): 99-105

65.Dickler, A. Xoft Axxent® electronic brachytherapy_a new device for delivering brachytherapy to the breast. Nature Clinical Practice Oncology 2009 6(3): 138-42

66.Demirci, S. Radiation-Induced Cardiac Toxicity After Therapy for Breast Cancer: Interaction Between Treatment Era and Follow-Up Duration. International Journal of Radiation Oncology*Biology*Physics 2009 73(4): 980-987

67.Garg, A. Effects of Variable Placement of Superior Tangential/Supraclavicular Match Line on Dosimetric Coverage of Level III Axilla/Axillary Apex in Patients Treated With Breast and Supraclavicular Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2009 73(2): 370-374

68.Goddo, SM. Helical Tomotherapy Planning for Left-Sided Breast Cancer Patients With Positive Lymph Nodes: Comparison to Conventional Multiport Breast Technique. International Journal of Radiation Oncology*Biology*Physics 2009 73(4): 1243-1251

69.Harris, E. Characterization of Target Volume Changes During Breast Radiotherapy Using Implanted Fiducial Markers and Portal Imaging. International Journal of Radiation Oncology*Biology*Physics 2009 73(1): 958-966

70.Hurkmans, C. Significance of breast boost volume changes during radiotherapy in relation to current clinical interobserver variations. Radiotherapy and Oncology 2009 90(1): 60-65

71.Jain, P. Inter-fraction motion and dosimetric consequences during breast intensity-modulated radiotherapy (IMRT) Radiotherapy and Oncology 2009 90(1):93-98

72.Johansson, B. Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1–T2 breast cancer: First long time results from a clinical study. Radiotherapy and Oncology 2009 90(1): 30-35

73.Kunkler, I. Breast Radiotherapy: Considerations in Older Patients. Clinical Oncology 2009 21(2): 111-117

74.Li, XA. Variability of Target and Normal Structure Delineation for Breast Cancer Radiotherapy: An RTOG Multi-Institutional and Multiobserver Study. International Journal of Radiation Oncology*Biology*Physics 2009 73(1): 944-951

75.Livi, L. Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience. International Journal of Radiation Oncology*Biology*Physics 2009 73(2):

365-369

76.Lukens, JN. Regional Nodal Recurrence After Breast Conservation Treatment With Radiotherapy for Women With Early-Stage Breast Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2009 73(5): 1475-1481

77.Major, T. Dosimetric experience with accelerated partial breast irradiation using image-guided interstitial brachytherapy. Radiotherapy and Oncology 2009 90(1):48-55

78.Mannino, M. Accelerated partial breast irradiation trials: Diversity in rationale and design. Radiotherapy and Oncology 2009 91(1): 16-22

79.Miles, E. Dosimetry and field matching for radiotherapy to the breast and supraclavicular fossa. Radiotherapy and Oncology 2009 91(1): 42-48

80.Moon, SH. Dosimetric comparison of four different external beam partial breast irradiation techniques: Three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiotherapy and Oncology 2009 90(1): 66-73

81.Morganti, A. Phase I–II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. Radiotherapy and Oncology 2009 90(1): 86-92

82.Nguyen, B. Practical Applications of Nuclear Medicine in Imaging Breast Cancer. Current Problems in Diagnostic Radiology 2009 38(2): 68-83

83.Offersen, B. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: A systematic review. Radiotherapy and Oncology 2009 90(1): 1-13

84.Pignol, JP. Tolerance and Acceptance Results of a Palladium-103 Permanent Breast Seed Implant Phase I/II Study. International Journal of Radiation Oncology*Biology*Physics 2009 73(5): 1482-1488

85.Reed, V. Automatic Segmentation of Whole Breast Using Atlas Approach and Deformable Image Registration. International Journal of Radiation Oncology*Biology*Physics 2009 73(5): 1493-1500

86.Richards, G. Pulsed reduced dose-rate radiotherapy: A novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Breast Cancer Research and Treatment 2009 114(2): 307-313

87.Scanderberg, D. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiotherapy and Oncology 2009 90(1): 36-42

88.Schwarz-Dose J. Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose. Journal of Clinical Oncology. 27(4):535-41, 2009 Feb 1.

89.Taylor, C. Estimating Cardiac Exposure From Breast Cancer Radiotherapy in Clinical Practice. International Journal of Radiation Oncology*Biology*Physics 2009 73(4): 1061-1068

90.Thomas, C. An anthropomorphic phantom study of visualisation of surgical clips for partial breast irradiation (PBI) setup verification. Radiotherapy and Oncology 2009 90(1): 56-59

91.Zhang, J. Comparing Digital Tomosynthesis to Cone-Beam CT for Position Verification in Patients Undergoing Partial Breast Irradiation. International Journal of Radiation Oncology*Biology*Physics 2009 73(1): 952-957

Supportive Care & Symptom Management

92.Alexander S. Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. Journal of Clinical Oncology. 27(8):1197-201, 2009 Mar 10.

93.Alfano CM. Exercise and dietary change after diagnosis and cancer-related symptoms in long-term survivors of breast cancer: CALGB 79804. Psycho-Oncology. 18(2):128-33, 2009 Feb.

94.Andersen, R. Involvement in Decision-Making and Breast Cancer Survivor Quality of Life. Health Psychology. 28(1):29-37, January 2009.

95.Andersen, B. In Sickness and in Health: Maintaining Intimacy After Breast Cancer Recurrence. Cancer Journal. 15(1):70-73, January/February 2009.

96.Ashing-Giwa KT. Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncology Nursing Forum. Online. 36(1):79-88, 2009 Jan.

97.Ballinger, R. Quality of Life and Patient-reported Outcomes in the Older Breast Cancer Patient. Clinical Oncology 2009 21(2): 140-155

98.Baucom DH. A couple-based intervention for female breast cancer. Psycho-Oncology. 18(3):276-83, 2009 Mar.

99.Belkacemi, Y. Partial breast irradiation as sole therapy for low risk breast carcinoma: Early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiotherapy and Oncology 2009 90(1): 23-29

100.Bicego, D. Effects of Exercise on Quality of Life in Women Living with Breast Cancer: A Systematic Review. Breast Journal. 15(1):45-51, January/February 2009.

101.Christensen, S. Prevalence and risk of depressive symptoms 3_4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Research and Treatment 2009 113(2): 339-355

102.Clayton MF. Patient-centered communication during oncology follow-up visits for breast cancer survivors: content and temporal structure. Oncology Nursing Forum. Online. 36(2):E68-79, 2009 Mar.

103.Collins ED. Can women with early-stage breast cancer make an informed decision for mastectomy?. Journal of Clinical Oncology. 27(4):519-25, 2009 Feb 1.

104.Collins B. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology. 18(2):134-43, 2009 Feb.

105.Courneya, K. Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy. Breast Cancer Research and Treatment 2009 114(1): 179-87

106.Damstra, R.Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature. Breast Cancer Research and Treatment 2009 113(2): 199-206

107.Den Oudsten BL. The WHOQOL-100 has good psychometric properties in breast cancer patients. Journal of Clinical Epidemiology. 62(2):195-205, 2009 Feb.

108.Dougall, A. Coping With Genetic Testing for Breast Cancer Susceptibility. Psychosomatic Medicine. 71(1):98-105, January 2009.

109.Eremin, O. Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast cancer undergoing multimodality therapy: A randomised controlled trial. The Breast 2009 18(1): 17-25

110.Fan HG. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer. Psycho-Oncology. 18(2):156-61, 2009 Feb.

111.Fenlon DR. Menopausal hot flushes after breast cancer. European Journal of Cancer Care. 18(2):140-8, 2009 Mar.

113.Field, KM. Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer. European Journal of Cancer 2009 45(4): 551-560

114.Fobair, P. Concerns About Sexuality After Breast Cancer. Cancer Journal. 15(1):19-26, January/February 2009.

115.Frieswijk N. Being needy versus being needed: the role of self-regulatory focus in the experience of breast cancer. British Journal of Health Psychology. 14(Pt 1):69-81, 2009 Feb.

116.Fuller, S. Adjustment Issues Related to Bilateral Prophylactic Mastectomy in Women at Elevated Risk of Developing Breast Cancer. Plastic Surgical Nursing. 29(1):33-38, January/March 2009.

117.Halkett, G. How do radiation oncology health professionals inform breast cancer patients about the medical and technical aspects of their treatment? Radiotherapy and Oncology 2009 90(1):153-159

118.Hines SL. Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer. Journal of Clinical Oncology. 27(7):1047-53, 2009 Mar 1.

119.Irwin ML. Randomized Controlled Trial of Aerobic Exercise on Insulin and Insulin-like Growth Factors in Breast Cancer Survivors: The Yale Exercise and Survivorship Study. Cancer Epidemiology, Biomarkers & Prevention. 18(1):306-13, 2009 Jan.

120.Jagsi R. Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process. Cancer. 115(6):1185-93, 2009 Mar 15.

121.Jones AL. Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring. British Journal of Cancer. 100(5):684-92, 2009 Mar 10.

122.Katz ML. Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer. Cancer and Leukemia Group B 79804. Cancer. 115(3):480-8, 2009 Feb 1.

123.Kenemans, P. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. The Lancet Oncology 2009 10(2): 135-146

124.Lee, S. Chemotherapy-related amenorrhea in premenopausal women with breast cancer. Menopause. 16(1):98-103, January 2009.

125.Levine EG. The benefits of prayer on mood and well-being of breast cancer survivors. Supportive Care in Cancer. 17(3):295-306, 2009 Mar.

126.Liu L. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psycho-Oncology. 18(2):187-94, 2009 Feb.

127.Manne S. Cognitive and social processes predicting partner psychological adaptation to early stage breast cancer. British Journal of Health Psychology. 14(Pt 1):49-68, 2009 Feb.

128.Mehlsen M. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology. 18(3):248-57, 2009 Mar.

129.Mendonca MA. Neutrophil count is not associated with infection episodes in breast cancer patients treated with anthracycline-based chemotherapy. European Journal of Cancer Care. 18(2):184-90, 2009 Mar.

130.Minton, A. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. European Journal of Cancer 2009 45(3): 384-392

131.Norman SA. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. Journal of Clinical Oncology. 27(3):390-7, 2009 Jan 20.

132.Parker, P. Breast Cancer: Unique Communication Challenges and Strategies to Address them. Breast Journal. 15(1):69-75, January/February 2009.

134.Paskett E. Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541. Cancer. 115(5):1109-20, 2009 Mar 1.

135.Rabin C. Exercise and relaxation intervention for breast cancer survivors: feasibility, acceptability and effects. Psycho-Oncology. 18(3):258-66, 2009 Mar.

136.Reeves GK. Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. British Journal of Cancer. 100(3):538-44, 2009 Feb 10.

137.Schnur JB. A Randomized trial of a cognitive-behavioral therapy and hypnosis intervention on positive and negative affect during breast cancer radiotherapy. Journal of Clinical Psychology. 65(4):443-55, 2009 Apr.

138.Skrzypulec, V. Biopsychosocial functioning of women after mastectomy. Journal of Clinical Nursing. 18(4):613-619, February 2009.

139.SVENSK, A. Art therapy improves experienced quality of life among women undergoing treatment for breast cancer: a randomized controlled study. European Journal of Cancer Care. 18(1):69-77, January 2009.

140.Swain, S. Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Breast Cancer Research and Treatment 2009 113(2): 315-320

141.Swenson KK. Case-control study to evaluate predictors of lymphedema after breast cancer surgery. Oncology Nursing Forum. Online. 36(2):185-93, 2009 Mar.

142.Vodermaier A. Contextual factors in shared decision making: a randomised controlled trial in women with a strong suspicion of breast cancer. British Journal of Cancer. 100(4):590-7, 2009 Feb 24.

143.von Minckwitz, G. Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis. European Journal of Cancer 2009 45(4): 608-617

144.Waltman, N. Vitamin D Insufficiency and Musculoskeletal Symptoms in Breast Cancer Survivors on Aromatase Inhibitor Therapy. Cancer Nursing. 32(2):143-150, March/April 2009.

145.Wielgus KK. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncology Nursing Forum. Online. 36(1):38-48, 2009 Jan.

146.Yang HC. Marital quality and survivorship: slowed recovery for breast cancer patients in distressed relationships. Cancer. 115(1):217-28, 2009 Jan 1.

Surgery

147.Axelsson, C. Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer. British Journal of Surgery. 96(1):40-46, January 2009.

148.Britton PD. Use of ultrasound-guided axillary node core biopsy in staging of early breast cancer. European Radiology. 19(3):561-9, 2009 Mar.

149.Classe JM. Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of ganglion sentinelle et chimiotherapie neoadjuvante, a French prospective multicentric study. Journal of Clinical Oncology. 27(5):726-32, 2009 Feb 10.

150.Dixon, JM. Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer . European Journal of Cancer 2009 45(5): 795-799

151.Hewes, J. Importance of routine cavity sampling in breast conservation surgery. British Journal of Surgery. 96(1):47-53, January 2009.

152.Kim, M. Towards quantifying the aesthetic outcomes of breast cancer treatment: comparison of clinical photography and colorimetry. Journal of Evaluation in Clinical Practice. 15(1):20-31, February 2009.

153.Munhoz, AM. Immediate reconstruction following breast-conserving surgery: Management of the positive surgical margins and influence on secondary reconstruction. The Breast 2009 18(1): 47-54

154.Reed, M. The Role of Surgery in the Treatment of Older Women with Breast Cancer. Clinical Oncology 2009 21(2):] 103-110

155.Spillane, A. Minimal access breast surgery – A single breast incision for breast conservation surgery and sentinel lymph node biopsy. European Journal of Surgical Oncology (EJSO) 2009 35(4): 380-386

-----------------------

BREAST CANCER

March 2009

Current Awareness Bulletin

BEATSON WEST OF SCOTLAND CANCER CENTRE LIBRARY

EDUCATION SUITE, 1053 GT WESTERN RD, G12 0YN

0141 301 7285 kirsty.coltart@ggc.scot.nhs.uk

To:

[Name of recipient] _________________________________________

[Email address of recipient] _________________________________________

(Organisation/work email address preferred; please write clearly)

[Department] ________________________________________

[Site] ________________________________________

[Address] ________________________________________

[Address] ________________________________________

Return to the Library (please tick box)

LIBRARY, EDUCATION SUITE

BEATSON WEST OF SCOTLAND CANCER CENTRE

1053 GREAT WESTERN ROAD

GLASGOW, G12 0YN

[pic][?]€ƒ‡ˆŠŽ?fc

d

e

f

G

H

|

}

~

¦

§

H

I

o

ƒ

„

ðèäèäðäÜÖȾ´ð¦˜èä?è}è˜l˜[E*jhÚQª5?B*[pic]CJU[pic]\?^J[?]aJph!hÚQª5?B*[pic]CJ\?^J[?]aJph!hÚQª5?B*[pic]CJ\?^J[?]aJp _____________________________________________

_____________________________________________

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download